Benzinga | Mar 11, 2021 04:02PM EST

Ocular Therapeutix Q4 EPS $(1.21) Down From $(0.54) YoY, Sales $7.35M Miss $9.76M Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(1.21) per share. This is a 124.07 percent decrease over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $7.35 million which missed the analyst consensus estimate of $9.76 million by 24.69 percent. This is a 225.80 percent increase over sales of $2.26 million the same period last year.